Stivarga (regorafenib) — Medica
Soft tissue sarcoma
Initial criteria
- age ≥ 18 years
- advanced or metastatic disease
- diagnosis of non-adipocytic sarcoma OR pleomorphic rhabdomyosarcoma OR angiosarcoma
Approval duration
1 year
Soft tissue sarcoma
1 year